Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Boerhavia diffusa has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Boerhavia diffusa is used in traditional practice specifically to increase urine output, and any sustained increase in urine flow carries potassium and sodium with it. Anyone combining it with another diuretic, herbal or prescribed, should count the electrolyte losses together rather than separately. This is a pharmacological consequence, not a benefit claim.
Boerhavia diffusa appears in polyherbal preparations aimed at low iron status alongside iron-bearing botanicals and minerals. The reported work is formulation development and molecular docking rather than a clinical test in people. Read the pairing as convention with computational support, not as evidence that either component changes blood counts.
Both plants appear in the same traditional formula categories, and both have been studied for effects on oxidative markers in animal models. Their chemistry is unrelated: punarnavine and boeravinones on one side, diarylheptanoids on the other. The pairing is a formulation convention.
Both are used in formulas aimed at liver support and both have animal data on oxidative stress markers. There is no human work testing the combination. Marker changes in rodents are mechanistic signals and not outcomes in people.
Magnesium is reabsorbed largely in the thick ascending limb, and higher tubular flow reduces the fraction recovered. If Boerhavia diffusa does raise urine output in people, which so far rests on traditional use and animal reports rather than human measurement, magnesium losses would rise alongside potassium. The practical implication is monitoring rather than avoidance.
Piperine inhibits intestinal glucuronidation and some CYP-mediated clearance, which is the traditional reason it accompanies many Ayurvedic botanicals. Whether it changes exposure to punarnavine and the boeravinones specifically has not been measured. Regard it as a plausible formulation effect without ingredient-specific pharmacokinetic data.
Ginger accompanies punarnava in several classical preparations, historically as a digestive adjuvant rather than as an active partner. The rationale is textual and traditional. No controlled work isolates what ginger contributes to the pairing.
Nothing specific on file for Boerhavia diffusa. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 3 we read for Boerhavia diffusa. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.